ARCHIVES

As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal

This article is from The Cancer Letter archive.

Vol. 21 No. 05 | February 3, 1995

Download PDF Visit The Full Archive

Related Articles

No Proof Fiber Is Anticarcinogenic, Newell Says, But diet should Include Anyway

May 18, 1979

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

April 22, 1988

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007

Funding Opportunities (8-page issue).

April 25, 2003

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993